Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on August 1, 2018, to report its financial results for the second quarter ended June 30, 2018. The filing primarily consists of a press release (Exhibit 99.1) detailing these results, which are being furnished and not deemed "filed" under Section 18 of the Exchange Act. Investors should refer to the press release for the specific financial performance metrics.
Key Highlights
- 1IDEXX Laboratories announced its Q2 2018 financial results on August 1, 2018.
- 2The company released a press release (Exhibit 99.1) detailing the second quarter financial performance.
- 3The information is furnished under Item 2.02 of the 8-K filing.
- 4The furnished information is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
- 5Brian P. McKeon, EVP, CFO, and Treasurer, signed the report.
- 6No extended transition period for new/revised accounting standards has been elected.
Frequently Asked Questions
The specific financial results for the quarter ended June 30, 2018, are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing.
Information furnished under Item 2.02 is generally for informational purposes and is not subject to the same liabilities as information that is 'filed' with the SEC, particularly under Section 18 of the Exchange Act. It means the company is providing the information but not formally integrating it into its SEC filings for liability purposes.
Brian P. McKeon is the Executive Vice President, Chief Financial Officer, and Treasurer of IDEXX Laboratories, Inc., and he signed this 8-K report on behalf of the company.